TNNI3 and coronary artery disorder: Even after adjusting for potential confounders, such as coronary artery disease (HR 1.24, p = 0.310) and medication use (ACE inhibitors/ARBs and Beta-blockers), baseline hs-cTnI and NT-proBNP levels remained non-significant predictors of AHREs.